Showing results (51-60 of 119) with videos related to
Sort By:
Pageof 12
American Journal of Clinical Oncology|December 1, 1994
Weekly levofolinic acid and 5-fluorouracil plus hydroxyurea in metastatic gastrointestinal adenocarcinomasV Gebbia, R Valenza, A Testa, et al.Anti-Cancer Drugs|January 22, 1998
Cisplatin and epirubicin plus oral lonidamine as first-line treatment for metastatic breast cancer: a phase II study of the Southern Italy Oncology Group (GOIM)V Gebbia, N Borsellino, A Testa, et al.Oncology Reports|May 20, 2011
Usefulness of oral medroxyprogesterone acetate in the management of cancer-related cachexia-anorexia syndromeA Testa, V Gebbia, N Borsellino, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 1, 1995
Treatment of recurrent and/or metastatic squamous cell head and neck carcinoma with a combination of vinorelbine, cisplatin, and 5-fluorouracil: a multicenter phase II trialV Gebbia, G Mantovani, B Agostara, et al.Cancer|September 15, 1996
Treatment of advanced adenocarcinomas of the exocrine pancreas and the gallbladder with 5-fluorouracil, high dose levofolinic acid and oral hydroxyurea on a weekly schedule. Results of a multicenter study of the Southern Italy Oncology Group (G.O.I.M.)V Gebbia, E Majello, A Testa, et al.Journal of Cancer Research and Clinical Oncology|January 1, 1994
Etoposide, doxorubicin (Adriamycin) and cisplatin regimen in advanced gastric adenocarcinoma: experience with a lower dose scheduleV Gebbia, R Valenza, A Testa, et al.Proceedings of the National Academy of Sciences of the United States of America|December 1, 1987
Antineoplastic bryostatins are multipotential stimulators of human hematopoietic progenitor cellsW S May, S J Sharkis, A H Esa, et al.American Journal of Clinical Oncology|August 1, 1995
Vinorelbine plus cisplatin in recurrent or previously untreated unresectable squamous cell carcinoma of the head and neckV Gebbia, A Testa, C Di Gregorio, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 9, 2006
FOLFIRI with or without celecoxib in advanced colorectal cancer: a randomized phase II study of the Gruppo Oncologico dell'Italia Meridionale (GOIM)E Maiello, F Giuliani, V Gebbia, et al.Oncology|July 1, 1996
Epidoxorubicin and double biochemical 5-fluorouracil modulation with folinic acid and human lymphoblastoid interferon in advanced gastric carcinoma: a multicentric phase II study of the Southern Italy Oncology Group (GOIM)G Colucci, E Maiello, V Gebbia, et al.Pageof 12